WntResearch is active in biotechnology. Today the main focus is on the development of drug candidates for various metastatic forms of cancer. The research is focused on studying the bodily-specific protein WNT-5a, which has been found to play a crucial role in the proliferation of tumour cells. The products are licensed to various stakeholders in the industry. The head office is in Malmö.

Quotes for WntResearch AB

Right Now

+/-
-0.14
%
-4,86%
Latest
2.74
High
3
Low
2.68
Volume
1 428 893
Turnover (SEK)
3 984 232
Value (MSEK)
144,7

Board

CEO

  • Peter Morsing

Chairman Of The Board

  • Gudrun Anstrén

Board

  • Jan Nilsson
  • Janna Sand-Dejmek
  • Martin Olovsson
  • Peter Ström
  • Tommy Andersson

Videos

Largest Owners

Name Capital % Votes % Date
Avanza Pension 11,09 11,09 2020-03-31
Nordnet Pensionsförsäkring 10,67 10,67 2020-03-31
Tommy Andersson 4,24 4,24 2020-03-31
Kjell Stenberg 3,03 3,03 2020-05-27
Lars-Erik Forsgårdh 1,83 1,83 2020-03-31
Leif Bertils 1,13 1,13 2020-03-31
Nils Qvarner 1,10 1,10 2020-03-31
Bostadsrättsbyggarna Svenska Holding AB 0,85 0,85 2020-03-31
Peter Nero 0,65 0,65 2020-03-31
Livförsäkringsbolaget Skandia 0,57 0,57 2020-03-31
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2020-08-13 Delårsrapport 2020-Q2

  • 2020-11-12 Delårsrapport 2020-Q3